U.S. Markets close in 5 hrs 13 mins

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.69+0.05 (+0.89%)
As of 10:46AM EDT. Market open.
People also watch
NVAXGALECLDXONCSSRPT
  • s
    sarath
    sarath
    I shorted this at $8.00 in June now it is at $5.66. Who is the idiot?I will cover it when the ApolloBio deal falls apart. Why their board can't approve it for this long and the Chinese government approval is not forthcoming? The deal was done 6 months ago and supposed to complete it during the first half 2017. Why should they pay $8 plus for apiece of #$%$ trading at $5.66?
  • H
    Hugo
    Hugo
    Inovio was known as Concord Energy when O & G stocks were hot.
    Inovio morphed into United Technology when tech stocks were hot.
    Inovio became Genetronics Biomedical when med stocks were hot.
    Inovio was adopted when biotech and pharma stocks were hot.

    Electroporation was hyped in the 1990s, then it failed in trials.
    It has since been reincarnated.
    Inovio now also hypes a cure for whatever disease is in the news (ebola, zika, MERS, chimichunga.....) but develops nothing.
    They hyped mice trials for infectious diseases, cures for cancer, DNA platforms, activators, pulsers, syncon, modulaters, percolaters, immunos ...... but have developed nothing in 38 years.

    How long can they continue to con gullible saps?
    Kimmie is like the elixir salesman.
    "Science" that produces nothing in nearly 4 decades is SCIENCE FICTION.
    Are you really so impressionable? Do you invest in fancy sounding names and hype or in accomplishment and actual results?

    This one has SCAM written all over it.
  • i
    ignatius
    ignatius
    If Marty Schmemag of Gullible Saps Inc. said that he had a cure for cancer ........
    How long would it take you to realize that you were scammed?

    (a) After 10 years of NOTHING but dead mice?
    (b) After 20 years of NOTHING but hype?
    (c) After 30 years of NOTHING but cracked petri dishes?
    (d) After 35 years of NOTHING but conferences and junkets but not even one P3 trial?
    (e) Longer?

    Mike chose (e) again. It's the most popular selection of gullible saps.
  • i
    ignatius
    ignatius
    The DISCOUNTED DILUTIVE FINANCING was needed to raise more funds for managements' excessive compensation.
    2016 management compensation for 38 years of nothing:
    Kim ............ $2,973,605
    Bagarazzi .. $1,393,790
    Kies ........... $1,355,723
    Sardesai .... $1,392,782

    At least someone is making money here!!!
    They recently hired more pigs to feed at the trough.
    Over $7,000,000 for Kim, Bagarazzi, Kies and Sardesai in 2016 to run some mice studies?
  • i
    ignatius
    ignatius
    List of TERMINATED Partnerships:

    1) Pharma Patch plc
    2) PharmaTronics LLC
    3) Abbott
    4) Ethicon
    5) Boehringer Ingelheim
    6) Johnson & Johnson Research Pty Ltd
    7) Chiron
    8) Valentis
    9) Genteric
    10) Vical
    11) Merck
    12) Tripep
    13) Wyeth
    14) IAVI
    15) ChronTech
    16) Medimmune
    17) Roche

    Why did they all TERMINATE the partnerships?
    Inovio has nothing that works?
    What other possible reason would they all have TERMINATED?
    They found Kimmie's warehouse of dead mice?
  • i
    ignatius
    ignatius
    Gilead founded years AFTER Inovio has 24 approved drugs and 9 in Phase 3 Trials.
    Inovio has ZERO approved of anything and has ONE Phase 3 Trial which is sure to fail..
    Dead mice is all that baggies get here.
  • i
    ignatius
    ignatius
    Celgene founded AFTER Inovio has 22 approved drugs and 12 in Phase 3 Trials.
    Inovio has ZERO approved for anything and ONE drug in a Phase 3 Trial which is sure to fail.
    DILUTION, REVERSE SPLITS and HYPE is all that you get at Inovio.
  • s
    sarath
    sarath
    The Truth About INO
    -This company has nothing to show for 17 years, since 2000, the year Dr. Kim became the CEO
    -The losses amounts to around $500mm since that time.
    -There is 1 drug just getting into Phase 1 and few other compounds in P1/2
    -Phase 3 compound may have a FDA filing in 2022 if they get lucky with the trail numbers
    -How much money they will need from here to 2022? A few more dilutive issues as they burn $25mm per quarter.
    -In spite of attending many road shows, conferences INO's institutions ownership (25%) or so is limited to a bunch of index funds, quant funds and ETFs. Why quality, knowledgeable biotech/pharma players are not investing in INO?
    -Dr. Kim resorts to paid articles/interviews to promote the company and himself. His efforts are not working and the stock is going in the opposite direction.
    -INO jumps from one compound to another, based on CNN Breaking News (Zika, Mers, Ebola.._), to keep the retail investor interest alive
    -INO is run like a university lab not like a for profit company that benefit its true owners
    -Directors/top management get below market shares every year that they sell for merger profits. In April/May most, including Dr. Kim, cashed out before the shares started collapsing
    -Thi is the truth about Inovio
    -A few cult like idiots here will now say these are lies without giving any facts.
  • S
    Sayed
    Sayed
    Horrid looking chart - excessive valuation - I wouldn't pay $2.50 for your shares.
    When the market retreats from its highs, INO will be trading at $1 and change.
  • o
    options
    options
    Robert, is the long term plan to develop a product in the next 38 years or in the next 50 years?
    Will you be alive then?
    Patents on nothing that works are useless and worthless.
  • s
    sarath
    sarath
    Why Should anyone Buy this company?

    -Nearest FDA filing is in 2022. If they get lucky, approval in 2023 in a crowded market. That is like going toLas Vegas.
    -All the other products are in P1/P2
    -How much money INO will burn from here to 2023? $25mm per quarter.
  • d
    david
    david
    The dead dog bounce has concluded?
  • n
    nice
    nice
    Yes read the 10Q .... you will find that not one Phase 3 Trial has been completed in 38 years.
    The futility!
    Kimmie feeds mike hype and dead mice.
  • P
    Phil
    Phil
    A review of Inovio's accomplishments:
    Today marks 38 years of FAILURE:

    ( 1 ) Electroporation Failed
    ( 2 ) Pictovir Failed
    ( 3 ) ChronVac-C Failed
    ( 4 ) VG-1027 Failed
    ( 5 ) VGX-3400 Failed
    ( 6 ) VGX-3500 Failed
    ( 7 ) Bleomycin Failed

    VGX-3100 is next!

    Inovio has nothing that works - not one Phase 3 trial completed in 38 years.
  • m
    mass
    mass
    $200 to $5 and TWO Reverse Splits. Who is getting jittery? LOLOL
    Disinformation is mike (pineconebutt's) middle name.
    I hate to break this to you, the twice REVERSE SPLIT dung was dung years ago and it it is still dung now, dungier smelling dung.
    INO is the classic flush the toilet stock.
    It should never be bought because whatever the price is now, it will always drop lower.
  • A
    Adam
    Adam
    Hahah the circus clown shorts still making a clown out of themselves with their lies and fake news. Maybe they should make another 50 fake accounts and rotate through them and then someone might listen to them. Haha cover your short position losers.
  • S
    Sam
    Sam
    Short interest represents future demand for the stock. Short interest dropped from 14M to 8.6M shares and the stock is near its low? So shorts bought 5.4M shares to cover their short positions for a tidy profit and the stock price still dropped? THere must have been a lot of institutional and baggie selling which swamped the shorts buying. NOT GOOD! Not good at all!
  • A
    Adam
    Adam
    Check out Ino website. Tons of products in the pipeline. Huge buying opportunity here !!
  • A
    Adam
    Adam
    Great time to buy and hold. There's tons of product in the pipeline waiting for FDA submissions
  • s
    sarath
    sarath
    Master Promoter in Action!
    Ties INO 5401 to John McCain's cancer in the earnings call.
    Is it necessary? He will grab anything in the CNN breaking news.